Hui Shi
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Biomedical Engineering top 2%
- Genetics top 1%
- Immunology top 5%
- Topics
- Extracellular vesicles in disease (27 papers)MicroRNA in disease regulation (18 papers)Cancer-related molecular mechanisms research (11 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Hui Shi
97 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Molecular Biology 5.1k
- Cancer Research 3.0k
- Biomedical Engineering 1.4k
- Genetics 853
- Immunology 772
Countries citing papers authored by Hui Shi
This map shows the geographic impact of Hui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Shi more than expected).
Fields of papers citing papers by Hui Shi
This network shows the impact of papers produced by Hui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Shi. The network helps show where Hui Shi may publish in the future.
Co-authorship network of co-authors of Hui Shi
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Shi. A scholar is included among the top collaborators of Hui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Shi. Hui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | Tailoring traditional Chinese medicine in cancer therapybreakdown → | 33 |
| 3 | 16 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 23 | |
| 7 | 97 | |
| 8 | 20 | |
| 9 | 37 | |
| 10 | 52 | |
| 11 | 26 | |
| 12 | 44 | |
| 13 | 9 | |
| 14 | Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destructionbreakdown → | 354 |
| 15 | 42 | |
| 16 | 110 | |
| 17 | 102 | |
| 18 | 9 | |
| 19 | 9 | |
| 20 | 51 |
About Hui Shi
Hui Shi is a scholar working on Cancer Research, Rehabilitation and Molecular Biology, having authored 98 papers that have together received 7.7k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (27 papers), MicroRNA in disease regulation (18 papers) and Cancer-related molecular mechanisms research (11 papers). The work is most often cited by research in Cancer Research (3.0k citations), Rehabilitation (569 citations) and Genetics (853 citations). Hui Shi has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Hui Qian, Wenrong Xu, Xu Zhang, Bin Zhang, Lijun Wu, Xiao Yuan, Chwee Teck Lim, Kian Ping Loh, Wong Cheng Lee and Yu Wang. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.